Bladder cancer and Lynch syndrome

It is an inherited condition affecting DNA repair. A diagnosis of Lynch syndrome does not mean bladder cancer will develop, and a bladder cancer diagnosis does not by itself establish Lynch syndrome.

A clinician may consider the cancer type, age at diagnosis, previous cancers, and patterns of bowel, womb, or urinary tract cancers among relatives. Genetic counselling can clarify whether testing is suitable and what a result could mean for you and biological relatives.

If bladder cancer is present, its grade, stage, position, and molecular features guide care. Lynch syndrome is only one part of that assessment and does not determine treatment on its own.

Gather pathology reports and a family history covering which relatives had cancer and where it began. Ask whether referral to a genetics service is appropriate, whether tumour testing has been performed, and whether urinary monitoring should differ from routine care.

Blood in the urine, new urinary urgency, or difficulty emptying the bladder should be assessed rather than attributed to Lynch syndrome. Evaluation may include urine tests, imaging, and cystoscopy depending on the clinical picture.

Arrange a prompt medical assessment for visible blood in the urine, even if it stops, or for persistent urinary changes. Seek urgent care if you cannot pass urine, are passing clots, have heavy bleeding, or feel faint or severely unwell.

Ask whether your personal or family history meets criteria for genetic counselling, whether testing should begin with tumour tissue or a blood sample, and how a positive, negative, or uncertain result would change follow-up. If cancer has been diagnosed, ask which findings are actually driving the treatment recommendation.